IGC

Quote

Short

News

Articles

Message Board

IGC Pharma Inc. (NYSE : IGC ) News

IGC Pharma Inc. (NYSE: IGC) News Releases

IGC News Releases

June 02, 2026 08:30:00 am

ACCESS Newswire

IGC Pharma Adds Mount Sinai Clinical Site as CALMA Trial Advances Toward Completion and Topline Analysis

May 19, 2026 05:32:03 pm

SeekingAlpha

IGC Pharma GAAP EPS of -$0.02 in-line, revenue of $0.32M beats by $0.09M

May 19, 2026 05:30:00 pm

ACCESS Newswire

IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment

May 15, 2026 08:00:00 am

ACCESS Newswire

IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference

April 28, 2026 12:15:00 pm

ACCESS Newswire

IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase

April 22, 2026 08:30:00 am

ACCESS Newswire

IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion

April 20, 2026 08:30:00 am

ACCESS Newswire

IGC Pharma Secures Psilocybin Research Authorization, Expanding Focus on Neuropsychiatric Symptoms in Dementia

April 14, 2026 08:30:00 am

ACCESS Newswire

IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout

April 08, 2026 12:45:00 pm

ACCESS Newswire

Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts

April 07, 2026 08:00:00 am

ACCESS Newswire

IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account